Showing results (1651-1660 of 1,919) with videos related to

Sort By:
Pageof 192
Tomography (Ann Arbor, Mich.)|June 25, 2026
Biophysical Diffusion MRI Models Better Identify White Matter Tracts in EdemaIsaac E Prentiss, Sasha Hakhu, Jennapher Lingo VanGilder, et al.
Blood Cancer Journal|November 27, 2025
CDK9 is a dependency in GATA-3 driven and MCL-1 independent T-cell LymphomasChenguang Wang, Suhaib Abdelrahman, Xiangrong Geng, et al.
Plant Disease|February 8, 2019
First Report of Pepper mottle virus Infecting Tomato in HawaiiM J Melzer, J S Sugano, D Cabanas, et al.
Plant Biology (Stuttgart, Germany)|April 23, 2008
Effects of overexpression of endogenous phenylalanine ammonia-lyase (PALrs1) on accumulation of salidroside in Rhodiola sachalinensisL-Q Ma, D-Y Gao, Y-N Wang, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 17, 2016
Management algorithm for HIV-associated parotid lymphoepithelial cystsWaleed F Mourad, Shyamal Patel, Rebekah Young, et al.
Tissue Engineering. Part A|May 29, 2015
High-Throughput Screening of Surface Marker Expression on Undifferentiated and Differentiated Human Adipose-Derived Stromal CellsGraham G Walmsley, David A Atashroo, Zeshaan N Maan, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|November 18, 2024
Three-dimensional spatial distribution of lumbar paraspinal intramuscular fat revealed by spatial parametric mappingK A Weber, E O Wesselink, J Gutierrez, et al.
Cancers|January 21, 2022
The Alliance AMBUSH Trial: Rationale and DesignAnita Mahajan, Helen Shih, Marta Penas-Prado, et al.
The Pharmacogenomics Journal|January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapyA Pohl, A El-Khoueiry, D Yang, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
OATP1B1 polymorphism as a determinant of erythromycin dispositionC S Lancaster, G H Bruun, C J Peer, et al.
Pageof 192